| SIU School of Medicine

Profiles

Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma

Active recruiting

The goal of this study is to conduct the first randomized-controlled trial to determine the oncologic efficacy of lymph node dissection in participants with upper tract urothelial cell carcinoma.

Profiles

Health Care Molly Williams Healthcare Administrator, CHW Program Caleb Przykopanski Grants and Contracts Associate Kathryn Barnes Educational Coordinator Tanya Bakamba Community Health Worker Molli Carlyle Program Coordinator, Caring Hearts Aaliyah Lewis CHW Nicol Moore CHW Sam Nunes CHW Nicole Watts CHW FQHC Annette Reese Program Coordinator, CHW Program Abdul- Samed Al- Hassan CHW Susan Klein CHW Sarah Knowlton CHW Kyle Minert CHW Tonya O’Donnell CHW Bailey Sturgeon CHW Vince Hutchens Driver General Internal Medicine Dawn Small Program Coordinator, CHW Program Laura Hendricks CHW Derek

Trial

Neurology

A 6-month (stage 1) & 18-month (stage 2) prospective, randomized, placebo-controlled, doubleblind dual clinical trial investigating efficacy and safety of buntanetap in treating participants with early Alzheimer’s disease

Active recruiting

In this study, the safety and efficacy of buntanetap will be assessed in a diverse population of early AD participants via a randomized, double-blind, placebo-controlled, multicenter Phase 3 trial.

Trial

Neurology

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated with Mild to Moderate Alzheimer’s Disease (MINDSET 2)

Active recruiting

The purpose of this research is to learn if the experimental study drug KarXT + KarX-EC works to treat thinking and memory problems as well as improve overall function in people with Alzheimer’s disease (AD).

General Results

Brieana Kesterson

Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma

Kathryn Semon

Team members

A 6-month (stage 1) & 18-month (stage 2) prospective, randomized, placebo-controlled, doubleblind dual clinical trial investigating efficacy and safety of buntanetap in treating participants with early Alzheimer’s disease

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated with Mild to Moderate Alzheimer’s Disease (MINDSET 2)

Student organizations and interest groups

SIU PhD student Sujata Pandey wins prestigious national fellowship to advance hearing loss research

SIU PhD student Sujata Pandey wins prestigious national fellowship to advance hearing loss research

SIU PhD student Sujata Pandey wins prestigious national fellowship to advance hearing loss research